Excerpts

In contrast, DRE males showed a trend towards elevated CCL2 ( p = 0.125) and CCL5 ( p = 0.066) compared to healthy males (Fig. 3 G,H).

Patients with TBI showed a trend towards elevated PER2 ( OR = 3.00 [0.84–9.33], P = 0.125) , but not towards delirium occurrence ( P = 0.556).

In contrast, posterior mPFC shows a nonsignificant trend in the opposite direction (r = 0.24; p = 0.126).

5 ) and a decreasing trend from 2020 to 2023 (APC = −38.1%, 95% CI: −70.0% to 27.9%, P = 0.1260, Table 5 ; Fig. 5 ), neither of which was statistically significant.

Notably, transplanted patients who received RQ-PCR MRD-negative autografts, regardless of whether obtained after the first or the second R-HD-ARA-C course, showed a trend towards PFS advantage, even if not statistically significant (median PFS 56 and 37 months for negative and positive LK MRD samples respectively, p = 0.128) (Fig. 4 ).

There was a trend toward significance for IDH status and KPS ≥ 70 at last follow-up ( p = 0.13 and 0.06, respectively).

5 F) and tended towards significance in the rodent model (control: 1.01 ± 0.10, LPS: 1.19 ± 0.23, P = 0.13; Fig. 5C).

ctHPV16DNA/wbMTV did not correlate with texture features in Groups A and B, but had a negative trend with LGZE (Rho = − 0.29, p = 0.13 [ p < 0.05 before correction]) in Group B.

However, at T d = 27.6 ms, a weak trend was observed between them (R = 0.63, P = 0.13 for MCF-7 and R = 0.31, P = 0.26 for MDA-MB-231).

Importantly, higher relative proportion of resting mast cells in HCC showed a trend toward shorter survival of patients (p = 0.13, data not shown) Total Immune cell infiltration and its correlation with immune cell types The extent of immune cell infiltration into tumors has important prognostic value in HCC and other cancers 5 , 9 , 15 , 19 .

Similarly, KB showed a trend for attenuation of HDM exposure induced IL-13 levels (p = 0.13).

Two-way ANOVA showed marginally significant site effect on CSE ( p -value = 0.13) and the post hoc test showed CSE is lower at HH and ZZ than QY ( Fig. 2c ).

A nonsignificant trend toward higher PD rates was observed in CRC patients (OR = 2.12, 95% CI: 0.80–5.59; p = 0.13), with low heterogeneity (I2 = 17%).

4 ) revealed a positive trend in OS when BW gain was observed at 3 weeks (11.8 vs. 6.3 months, p = 0.1308), and OS significantly improved when BW gain was observed at 12 weeks (14.9 vs. 6.8 months, p = 0.0285).

Although non-significant (NS), patients with incongruent results (one low/one high, n = 10) showed a trend of having a favorable prognosis compared to patients with high results from both modalities (log-rank p = 0.131), but inferior compared to patients with low uPAR-estimates on both modalities (p = 0.136).

Concordantly, high CXCL10 [OR 0.58 (0.4–0.84); p = 0.004] and high IL-6/CXCL10 [OR 0.59 (0.39–0.87); p = 0.011] categories were significantly associated with lower probability of immediate kidney function, while high IL-6 category showed a weak trend [OR 0.75 (0.51–1.09); p = 0.131].

Not surprisingly however, Hs 578T was the highest SQLE expresser in our panel, and indeed also SQLE GE levels showed a trend for correlation with terbinafine IC 50 in the six lines panel (ρ = −0.71, P = 0.1361).

14.2 months; hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.68-0.99; P = 0.039), with a favorable trend observed for progression-free survival (PFS) as well (median PFS: 10.6 vs. 9.3 months; HR: 0.85; 95% CI: 0.68-1.05; P = 0.137) 12 .

Although it was with marginal significance, the lower gene expressions of Tlr4 ( p = 0.138, t -test vs.

Compared with that in the clopidogrel + IR group, the tail bleeding time showed a decreasing trend in the TMAO + clopidogrel + IR group (10.5 min ± 8.63 min, P = 0.139) (Fig. 2 ).

The results showed a strong trend towards higher perfusion rates (~58% greater, p = 0.14), and significantly higher glucose uptake in LCC6 HER-2 (~2-fold greater; p = 0.025), relative to control tumours.

The only comparison that survived multiple comparison correction (BH critical value = 0.03) was a significant interaction between gender and CS–IFG phase locking in the beta band (β = 417.99, SE = 189.28, t (55 = 2.21, p = .03, LLCI = 38.65, ULCI = 797.33); simple slope analyses indicated that women tended to perform worse as their CS–IFG phase locking increased in response to STEMIs (β = −6.89, SE = 4.08, t (55) = −1.69, p = .097, LLCI = −401.06, ULCI = 34.18), whereas men showed a nonsignificant trend in the opposite direction (β = 8.81, SE = 5.82, t (55) = 1.51, p = .14, LLCI = −76.15, ULCI = 545.26).

While S1 showed a trend towards worse prognosis when compared to S2, this difference was not statistically significant in cox regression analysis ( p = 0.14).

1E ), only for DMFS of ER+ patients, low EEF1A1 levels showed a weak trend towards statistically significant association with poor survival (p = 0.14, n = 161).

However, this difference was only marginally statistically significant (Whole Model F (2,15) = 2.20, P = 0.14; Pollen treatment: F (1,1) = 4.10, P = 0.06) and this was most likely the result of the reduced sample size and high variance.